Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Amide. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101781256B details a high-yield CDI-mediated amidation route for benzimidazole derivatives, offering cost reduction in API manufacturing and improved supply chain reliability.
Patent CN120349258A reveals metal-free photocatalytic deuteration. Offers significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing globally today.
Patent CN120349258A reveals mild photocatalytic deuteration. Offers cost reduction and supply chain reliability for pharma intermediates.
Advanced synthesis of ursolic acid pyrimidine amide derivatives via novel heterocyclic modification. Reliable supplier for high-purity antitumor pharmaceutical intermediates.
Patent CN114096529A details a scalable route for Asciminib intermediates using improved Suzuki coupling and amide formation, offering significant cost and purity advantages for pharmaceutical manufacturing.
Novel reduction method for dexpramipexole dihydrochloride. High purity, mild conditions, cost-effective API manufacturing solution.
Patent CN1019300B reveals stable amine salt acylation for high-yield cephalosporins, offering cost-effective supply chain solutions.
Novel synthesis route for insulin resistance intermediates. Cost-effective scale-up and high purity for diabetes drug manufacturing.
Patent CN103641731B reveals a high-yield synthesis route for phenylacetamide derivatives. Discover cost-effective manufacturing and supply chain advantages for agrochemical intermediates.
Patent CN110845534A details a novel oxidative coupling method for phosphoramide compounds, offering high stereoselectivity and yield for reliable pharmaceutical intermediate supply chains.
Patent CN111270260A introduces a green electrochemical Rh-catalyzed alkenylation method, offering cost reduction and scalable solutions for fine chemical manufacturing.
Patent CN107686456A reveals safer synthesis for quinolone intermediates. Achieve high purity and cost reduction in pharmaceutical intermediates manufacturing with scalable routes.
Patent CN110218158A enables green aqueous amide synthesis. Reduces toxic waste and simplifies supply chain for high-purity pharmaceutical intermediates manufacturing.
Patent CN108084085B reveals a high-yield synthesis route for kinase inhibitor intermediates. Discover cost-effective manufacturing and supply chain advantages.
Metal-free electrochemical method for 2-aminoindoles. Reduces cost and waste in pharmaceutical intermediate manufacturing via green aqueous systems.
Patent CN110627717B reveals a novel Pd-catalyzed C-H alkenylation for branched 1,4-diene amides. Discover cost-effective, scalable routes for pharmaceutical intermediates.
Patent CN102775389A details a robust 3-step synthesis for kinase inhibitors. Discover cost-effective manufacturing and reliable supply chain solutions.
Patent CN114149386A discloses potent amide-based ALDH2 agonists with improved solubility. We analyze the scalable synthesis routes for pharmaceutical intermediates.
Patent CN101709051A details a safe, normal-pressure synthesis of 2-amino-3-chloro-5-(trifluoromethyl)pyridine using sodium amide, offering significant cost reduction in agrochemical intermediate manufacturing.
Novel 3-step route for Mirabegron eliminates Boc protection, reducing cost and complexity. Ideal for reliable API intermediate supplier partnerships.